FDA Inspection
William A. Gahl, MD, PhDWilliam A. Gahl, MD, PhD – FDA Inspection, Jul 8, 2010
Record Details
This FDA Inspection record concerns William A. Gahl, MD, PhD, with an inspection on July 8, 2010, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- William A. Gahl, MD, PhD
- Inspection Date
- July 8, 2010
- Product Type
- Drugs
View Company Profile
ID · 2f28a7f3-c92f-46c6-bdf0-deb895f970b0
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 673146
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
3- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(a)Accountability records
- 21 CFR 50.25(a)(1)Statement of research, purpose, duration of participation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of William A. Gahl, MD, PhD
1| Date | Classification | Office | Project area |
|---|---|---|---|
| December 19, 2024 | VAI | Baltimore District Office | Bioresearch Monitoring: Human Drugs |
Other documents for William A. Gahl, MD, PhD
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.